|
[1]
|
段华, 陈蓉, 汪沙, 罗新, 等. 绝经生殖泌尿综合征临床诊疗专家共识[J]. 中华妇产科杂志, 2020, 55(10): 659-666.
|
|
[2]
|
Schoenaker, D.A., Jackson, C.A., Rowlands, J.V., et al. (2014) Socioeconomic Position, Lifestyle Factors and Age at Natural Menopause: A Systematic Review and Meta-Analyses of Studies across Six Continents. International Journal of Epidemiology, 43, 1542-1562. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Rossouw, J.E., Anderson, G.L., Prentice, R.L., et al. (2002) Risks and Benefits of Estrogen plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women’s Health Initiative Randomized Controlled Trial. The Journal of the American Medical Association, 288, 321-333. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Harlow, S.D., Gass, M., Hall, J.E., Lobo, R., et al. (2012) Executive Summary of the Stages of Reproductive Aging Workshop+10: Addressing the Unfinished Agenda of Staging Reproductive Aging. The Journal of Clinical Endocrinology & Metabolism, 97, 1159-1168. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Avis, N.E., Crawford, S.L., Greendale, G., et al. (2015) Duration of Menopausal Vasomotor Symptoms over the Menopause Transition. JAMA Internal Medicine, 175, 531-539. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
舒宽勇, 邓卫平. 绝经激素治疗与绝经相关症状[J]. 中国实用妇科与产科杂志, 2020, 36(3): 206-209.
|
|
[7]
|
彭红发, 闫晓楠, 徐春琳. 绝经激素治疗与骨质疏松症[J]. 中国实用妇科与产科杂志, 2020, 36(3): 230-233.
|
|
[8]
|
El Khoudary, S.R., Aggarwal, B., Beckie, T.M., et al. (2020) Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation, 142, e506-e532.
|
|
[9]
|
Silvestri, R., Aricò, I., Bonanni, E., Bonsignore, M., et al. (2019) Italian Association of Sleep Medicine (AIMS) Position Statement and Guideline on the Treatment of Menopausal Sleep Disorders. Maturitas, 129, 30-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
王艳, 任慕兰. 绝经激素治疗与认知[J]. 中国实用妇科与产科杂志, 2020, 36(3): 221-224.
|
|
[11]
|
Maki, P.M., Kornstein, S.G., Joffe, H., et al. (2019) Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. Journal of Women’s Health, 28, 117-134. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
曹远奎, 张绍芬. 绝经、激素替代治疗与代谢综合征[J]. 中华糖尿病杂志, 2015, 4(1): 47-50.
|
|
[13]
|
Gartlehner, G., Patel, S.V., Feltner, C., et al. (2017) Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Evidence Report and Systematic Review for the US Preventive Services Task Force. The Journal of the American Medical Association, 318, 2234-2249. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Mauvais-Jarvis, F., Manson, J.E., Stevenson, J.C., et al. (2017) Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications. Endocrine Reviews, 38, 173-188. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
谢梅青, 陈蓉, 任慕兰. 绝经管理与绝经激素治疗中国指南(2018) [J]. 中华妇产科杂志, 2018, 53(11): 729-739.
|
|
[16]
|
Gemmell, L.C., Webster, K.E., Kirtley, S., et al. (2017) The Management of Menopause in Women with a History of Endometriosis: A Systematic Review. Human Reproduction Update, 23, 481-500. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Oliver-Williams, C., Glisic, M., et al. (2019) The Route of Administration, Timing, Duration and Dose of Postmenopausal Hormone Therapy and Cardiovascular Outcomes in Women: A Systematic Review. Human Reproduction Update, 25, 257-271. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Lee, S.R., Cho, M.K., Cho, Y.J., et al. (2020) The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine, 26, 69-98.
|
|
[19]
|
McNeil, M.A. and Merriam, S.B. (2021) Menopause. Annals of Internal Medicine, 174, itc97-itc112. [Google Scholar] [CrossRef]
|
|
[20]
|
Hickey, M., Szabo, R.A. and Hunter, M.S. (2017) Non-Hormonal Treatments for Menopausal Symptoms. British Medical Journal, 359, j5101. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
乔林, 熊英, 徐克惠. “中国绝经管理和绝经激素治疗指南(2018)”解读[J]. 实用妇产科杂志, 2019, 35(3): 184-187.
|
|
[22]
|
Genazzani, A.R., Monteleone, P., Giannini, A., et al. (2021) Pharmacotherapeutic Options for the Treatment of Menopausal Symptoms. Expert Opinion on Pharmacotherapy, 22, 1773-1791. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Thaung Zaw, J.J., Howe, P.R.C. and Wong, R.H.X. (2018) Postmenopausal Health Interventions: Time to Move on from the Women’s Health Initiative? Ageing Research Review, 48, 79-86. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Zhang, G.Q., Chen, J.L., Luo, Y., et al. (2021) Menopausal Hormone Therapy and Women’s Health: An Umbrella Review. PLoS Medicine, 18, e1003731. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Collaborative Group on Hormonal Factors in Breast Cancer (2019) Type and Timing of Menopausal Hormone Therapy and Breast Cancer Risk: Individual Participant Meta-Analysis of the Worldwide Epidemiological Evidence. The Lancet, 394, 1159-1168. [Google Scholar] [CrossRef]
|
|
[26]
|
Pinkerton, J.V. (2020) Hormone Therapy for Postmenopausal Women. The New England Journal of Medicine, 382, 446-455. [Google Scholar] [CrossRef]
|
|
[27]
|
Lobo, R.A. (2017) Hormone-Replacement Therapy: Current Thinking. Nature Reviews Endocrinology, 13, 220-231. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Valéra, M.C., Fontaine, C., Dupuis, M., et al. (2018) Towards Optimization of Estrogen Receptor Modulation in Medicine. Pharmacology & Therapeutics, 189, 123-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Zhang, S., Zhu, D., Mei, X., et al. (2021) Advances in Biomaterials and Regenerative Medicine for Primary Ovarian Insufficiency Therapy. Bioactive Materials, 6, 1957-1972. [Google Scholar] [CrossRef] [PubMed]
|